市场调查报告书
商品编码
1527046
全球光学成像系统市场 2024-2031Global Optical Imaging Systems Market 2024-2031 |
光学影像系统市场规模、份额和趋势分析报告(按产品(成像系统、光学成像软体和照明系统)、按应用(眼科、牙科、皮肤科、心臟病学、神经病学、肿瘤学、生物技术和研究等))技术(光学相干断层扫描、近红外光谱、高光谱成像和光声断层扫描)和最终用户(诊断成像中心、医院和诊所以及研究实验室)预测期(2024-2031)
预计在预测期内(2024-2031 年)光学成像系统市场将以 11.4% 的复合年增长率成长。随着光学相干断层扫描 (OCT)、光声成像和近红外光谱等成像技术的进步,光学成像系统变得越来越受欢迎。这些系统在诊断和监测眼部和心血管疾病以及促进肿瘤学领域的早期癌症检测方面发挥着重要作用。非侵入性诊断程序研发资金的增加是推动全球产业成长的关键因素。
Optical Imaging Systems Market Size, Share & Trends Analysis Report by Product (Imaging Systems, Optical Imaging Software, and Illumination Systems), by Application (Ophthalmology, Dentistry, Dermatology, Cardiology, Neurology, Oncology, Biotechnology and Research, and Others), by Technique (Optical Coherence Tomography, Near Infrared Spectroscopy, Hyperspectral Imaging, and Photoacoustic Tomography), and by End-User (Diagnostic Imaging Center, Hospitals and Clinics, and Research Laboratories) Forecast Period (2024-2031)
Optical imaging systems market is anticipated to grow at a CAGR of 11.4% during the forecast period (2024-2031). Optical imaging systems have become increasingly popular with advancements in imaging techniques such as optical coherence tomography (OCT), photoacoustic imaging, and near-infrared spectroscopy. These systems play an essential role in diagnosing and monitoring eye and cardiovascular diseases, as well as facilitating early cancer detection in the oncology field. The increased funding for R&D of non-invasive diagnostic procedures is a key factor driving the global industry growth.
Market Dynamics
Growing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases such as cardiovascular disease, cancer, and diabetes necessitates the use of advanced diagnostic tools like optical imaging systems for early detection and effective treatment planning. According to the World Health Organisation, in September 2023, chronic diseases were responsible for a significant number of global mortalities, with 41 million individuals mortality each year, accounting for 74.0% of all mortalities globally. These facts depict the urgency to address the major chronic diseases, such as cardiovascular diseases (17.9 million mortalities annually), cancers (9.3 million mortalities), chronic respiratory diseases (4.1 million mortalities), and mortalities (2.0 million deaths, including kidney disease caused by diabetes).
Increasing Geriatric Population
The geriatric population is highly susceptible to age-related diseases such as macular degeneration and cataracts. According to the World Health Organization (WHO), in October 2022, the global population of individuals aged 60 years and older is projected to increase significantly to 2.1 billion, with the number of individuals aged 80 years or older expected to triple to reach 426.0 million. Therefore, the growing geriatric population is anticipated to drive the demand for optical imaging systems for early diagnosis of chronic disorders.
Market Segmentation
Oncology is Projected to Emerge as the Largest Segment
The increasing number of cancer cases, ongoing oncology research and clinical trials, and the development of advanced optical imaging systems for the early diagnosis and on-time treatment of cancer are key factors driving this market segment's growth. According to the National Breast Cancer Foundation, in April 2024, breast cancer affects a significant number of individuals in the US, with approximately 1 in 8 women and a smaller number of men being diagnosed with the disease. In 2024, it is projected that 310,720 women and 2,800 men will receive a diagnosis of invasive breast cancer.
The global optical imaging systems market is segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Technological Advancements in Optical Imaging Technologies in North America
The regional market growth is driven by continuous technological advancements in optical imaging technologies such as improvements in resolution, sensitivity, and speed across the region. For instance, in November 2023, Fujifilm Healthcare Americas Corp. launched new medical systems at the Radiological Society of North America's (RSNA) annual meeting. The company possesses digital radiography suites, fluoroscopy systems, a 0.4T MRI system, and a 128-slice CT system. These systems aim to simplify X-ray scans, deliver consistent, efficient exams, and simplify exam access.
Asia-Pacific Holds Major Market Share
The high prevalence of chronic disorders with the growing geriatric population is a key factor driving the growth of the regional market. According to government statistics, in January 2024, China's population aged 60 and above accounted for approximately 297 million individuals in 2023, which represents 21.1% of the total population. The increasing healthcare expenditure across the region is further aiding the regional market growth.
The major companies serving the optical imaging systems market include Abbott Laboratories, Carl Zeiss AG, GE HealthCare Technologies Inc., PerkinElmer Inc., and Thermo Fisher Scientific Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in February 2024, Bruker Corp. acquired Spectral Instruments Imaging, a provider of preclinical in-vivo optical imaging systems. The acquisition fills a gap in the Bruker BioSpin Preclinical Imaging division, expanding its range of preclinical solutions for disease research.